Avience Biomedicals IPO Subscription Status

Avience Biomedicals IPO subscription started on 18 June, 2026 and will close on 22 June, 2026. The retail quota is 33.10%, QIB is 47.01% and NII is 14.24%. Avience Biomedicals IPO got a lot of interest, raising around ₹14,53,800 shares (agg. up to ₹30 Cr) Crores, with subscriptions [.] times overall, including [.] times by institutional investors, [.] times by non-institutional investors, and [.] times by retail investors. Shares are priced between ₹₹196 to ₹208 per share each and will be listed on the NSE.

Check Live IPO  Subscription List  👈

Upcoming

Last Updated - [.]

QIB - Qualified Institutional Buyers:	[.]x
NII - Non-Institutional Investors:	[.]x
SNII - Small Non-Institutional Investors:	[.]x
BNII - Big Non-Institutional Investors:	[.]x
RII - Retail Individual Investor:	[.]x
Total:	[.]x 👈

• Qualified Institutional Buyers: QIB
• Non-Institutional Investors: NII
• Small Non-Institutional Investors: SNII- Bid below ₹10L
• Big Non-Institutional Investors: BNII- Bid above ₹10L
• Retail Individual Investor: RII
• Employees Quota: EMP

IPO Activity	Date
Open Date:	18 June, 2026
Close Date:	22 June, 2026
Allotment Date:	23 June, 2026
Refund Date:	24 June, 2026
Shares Credit Date:	24 June, 2026
Listing Date:	25 June, 2026

Q.When Avience Biomedicals IPO Subscription will start?

Ans.The IPO subscription starts on 18 June, 2026 for Investors.

---

Q.What is the Avience Biomedicals IPO Subscription last date?

Ans.Avience Biomedicals IPO subscription last date is 22 June, 2026 for Investors.

---

Q.What is the Avience Biomedicals IPO Allotment Date?

Ans.Avience Biomedicals IPO allotment date is 23 June, 2026.

---

Q.What is the Avience Biomedicals IPO Listing Date?

Ans.Avience Biomedicals IPO listing date is 25 June, 2026. The IPO is to list on NSE.